Boston Scientific (BSX) Short-Term Debt repayments (2019 - 2026)

Boston Scientific's Short-Term Debt repayments history runs 6 years deep, the most recent figure standing at $259.0 million for Q1 2026.

• In Q1 2026, Short-Term Debt repayments fell 76.08% year-over-year to $259.0 million; the TTM figure through Mar 2026 stood at $771.0 million (down 28.81% YoY), while the FY2025 annual figure was $1.6 billion, up 216.47% from the prior year.
• Short-Term Debt repayments came in at $259.0 million for Q1 2026 at Boston Scientific, up from $12.0 million in the prior quarter.
• In the past five years, Short-Term Debt repayments ranged from a high of $1.1 billion in Q1 2025 to a low of $12.0 million in Q3 2025.
• A 4-year average of $434.7 million and a median of $379.5 million in 2025 frame the typical range for Short-Term Debt repayments.
• Across the five-year window, Short-Term Debt repayments surged 114.88% in 2025 and tumbled 76.08% in 2026, its largest moves.
• Boston Scientific's Short-Term Debt repayments stood at $250.0 million in 2022, then soared by 101.6% to $504.0 million in 2024, then tumbled by 97.62% to $12.0 million in 2025, then surged by 2058.33% to $259.0 million in 2026.
• According to Business Quant data, Short-Term Debt repayments over the past three periods registered $259.0 million, $12.0 million, and $500.0 million for Q1 2026, Q3 2025, and Q2 2025 respectively.

Peer Comparison